Latham & Watkins represented Terns Pharmaceuticals in the offering, while Davis Polk & Wardwell represented the underwriters. Terns Pharmaceuticals, Inc. (Nasdaq: TERN) has agreed to sell, by...
Terns Pharmaceuticals’ $65 Million Common Stock Offering
ADC Therapeutics’ $175 Million Senior Secured Term Loan and Existing Senior Secured Convertible Notes from Owl Rock and Oaktree
Homburger and Davis Polk & Wardwell advised ADC Therapeutics on the deal. DC Therapeutics SA (NYSE:ADCT), a commercial-stage biotechnology company headquartered in Switzerland, announced that it...
URUS’s $170 Million Acquisition of Trans Ova Genetics
Davis Polk advised Precigen on the deal. Precigen, Inc. executed the sale of its wholly-owned non-healthcare subsidiary, Trans Ova Genetics, L.C. (“Trans Ova”), an industry-leading animal...
Ormat Technologies’ $375 Million Convertible Senior Notes Offering
White & Case advised Ormat Technologies, while Davis Polk advised the representative of the several initial purchasers in the offering. Ormat Technologies, Inc. executed its offering of...
Grupo Aval’s Spinoff of BAC Holding International
Davis Polk advised Grupo Aval Acciones y Valores S.A. in the deal. Grupo Aval Acciones y Valores S.A. announced the unregistered spinoff of a 75% equity...
Stanley Black & Decker’s $1 Billion Senior Notes Offering
Skadden, Arps, Slate, Meagher & Flom represented Stanley Black & Decker, while Davis Polk & Wardwell advised the joint book-running managers and representatives of the underwriters...
Grupo Aval’s Consent Solicitation
Davis Polk advised Grupo Aval Acciones y Valores S.A. on the deal. Grupo Aval Acciones y Valores S.A. announced a solicitation of consents by its wholly...
Perion Network’s $180 Million Follow-on Public Offering
Davis Polk advised Perion Network Ltd., while Gornitzky represented the underwriters on the deal. Perion Network Ltd. upsized US$180 Million underwritten follow-on public offering of ordinary shares...
GT Gettaxi’s Business Combination with Rosecliff Acquisition
Davis Polk advised GT Gettaxi on the deal, while Latham & Watkins represented Rosecliff Acquisition Corp. Shearman & Sterling advised MCI Capital SA. GT Gettaxi (“Gett”) executed...
Inventiva’s At-The-Market Offering
Davis Polk advised the sales agent on the deal. Inventiva S.A., a clinical-stage biotechnological company, announced the implementation of an At-The-Market (“ATM”) program allowing the Company to...
On Running’s $858.4 Million Initial Public Offering
Davis Polk advised On Holding AG on the offering, while Cravath represented the underwriters. On Holding AG completed its initial public offering of 35,765,000 Class A...
SOPHiA GENETICS’ $234 Million Initial Public Offering on Nasdaq
Homburger and Davis Polk advised SOPHiA GENETICS on the deal. Lenz & Staehelin acted as Swiss counsel to the underwriters. SOPHiA GENETICS SA listed its shares...